0001062993-23-020120.txt : 20231103 0001062993-23-020120.hdr.sgml : 20231103 20231103183533 ACCESSION NUMBER: 0001062993-23-020120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231101 FILED AS OF DATE: 20231103 DATE AS OF CHANGE: 20231103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Geist William CENTRAL INDEX KEY: 0001832210 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 231377718 MAIL ADDRESS: STREET 1: 900 MIDDLESEX TURNPIKE STREET 2: C/O QUANTERIX CORPORATION CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-11-01 0000842023 BIO-TECHNE Corp TECH 0001832210 Geist William 614 MCKINLEY PL NE MINNEAPOLIS MN 55413 0 1 0 0 PRESIDENT, PROTEIN SCIENCES 0 Common Stock 9960 D Restricted Stock Units Common Stock 3360 3360 D Stock Options (Right to Buy) 100.39 2029-02-01 Common Stock 11936 11936 D Stock Options (Right to Buy) 100.39 2029-02-01 Common Stock 15912 15912 D Restricted Stock Units Common Stock 7140 7140 D Stock Options (Right to Buy) 94.52 2029-08-15 Common Stock 22200 22200 D Stock Options (Right to Buy) 94.52 2029-08-15 Common Stock 29600 29600 D Restricted Stock Units Common Stock 8377 8377 D Stock Options (Right to Buy) 84.61 2030-08-15 Common Stock 22544 22544 D Stock Options (Right to Buy) 84.61 2030-08-15 Common Stock 30059 30059 D Restricted Stock Units 2023-11-01 4 A 0 19857 0 A Common Stock 19857 19857 D Includes 6,640 shares of restricted stock for which the risk of forfeiture will lapse as to 3,320 shares on each of 2/1/2024 and 2/1/2025. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 3,980 shares vest on each of 2/1/2023 and 2/1/2024 and options to purchase 3,976 shares vest on each of 2/1/2025 and 2/1/2026. Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 7,400 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026. Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026. 9,929 restricted stock units vest on 11/1/2024 and 9,928 restricted stock units vest on 11/1/2025. /s/ Andrew Nick as Attorney-in-Fact for William Geist pursuant to Power of Attorney previously filed 2023-11-03